INIS
kazakhstan
100%
tuberculosis
77%
patients
62%
genes
60%
genetics
55%
mycobacterium tuberculosis
32%
drugs
30%
risks
29%
mutations
25%
data
24%
strains
23%
populations
19%
genotype
17%
variations
16%
epidemiology
15%
epilepsy
15%
vitamin d
15%
diseases
14%
control
13%
children
12%
length
10%
telomeres
10%
devices
10%
testing
10%
values
8%
cardiovascular diseases
8%
humans
8%
antibiotics
8%
host
8%
obesity
8%
evaluation
7%
heart failure
7%
isoniazid
7%
levels
6%
death
5%
assessments
5%
therapy
5%
antigens
5%
utilities
5%
collagen
5%
diet
5%
chromosomes
5%
bypasses
5%
carcinomas
5%
esophagus
5%
corrections
5%
infants
5%
Keyphrases
Kazakhstan
65%
Mycobacterium Tuberculosis (M. tb)
34%
Tuberculosis
23%
Whole Genome Sequencing
17%
Mycobacterium Tuberculosis Strains
16%
Kazakh
15%
Pulmonary Tuberculosis
15%
Tuberculosis Epidemiology
11%
Genetic Polymorphism
10%
Polymorphism
10%
Telomere Length
10%
Left Ventricular Assist Device
10%
Genetic Variants
7%
Whole-genome Sequence Data
7%
Drug Resistance
6%
Genomic Variants
6%
Heart Failure Patients
6%
Single nucleotide Polymorphism
6%
Life Expectancy
6%
Genetic Variation
6%
Host Genetics
6%
Obesity
6%
Genetic Factors
6%
Sudden Cardiac Death
5%
Cardiovascular Disease
5%
Multidrug-resistant
5%
High Risk
5%
Genotype
5%
Ventricular Tachycardia
5%
Sequence Variants
5%
Sputum
5%
MIRU-VNTR Genotyping
5%
Rifampicin Resistance
5%
Isoniazid-resistant
5%
Prison
5%
Penitentiary System
5%
Pyrazinamide
5%
Kazakh Patients
5%
Draft Genome Sequence
5%
TLR Polymorphism
5%
Fatal Ventricular Arrhythmia
5%
VDR Polymorphism
5%
Multidrug-resistant Mycobacterium Tuberculosis
5%
HeartWare
5%
Mechanical Circulatory Support
5%
Clinical Utility
5%
Vitamin D Status
5%
Vitamin D Pathway
5%
Congestive Heart Failure
5%
XDR Strains
5%
Biochemistry, Genetics and Molecular Biology
Whole Genome Sequencing
30%
Genotyping
27%
Genetics
18%
Mycobacterium Tuberculosis
18%
Genetic Divergence
13%
Next Generation Sequencing
12%
Drug Resistance
10%
Single-Nucleotide Polymorphism
10%
Telomere Length
10%
Variable Number Tandem Repeat
9%
Single Nucleotide Polymorphism
8%
Prevalence
7%
Life Expectancy
7%
Genetic Polymorphism
6%
Case-Control Study
6%
CHRNA2
6%
Cardiac Dysrhythmia
6%
Genetic Variation
5%
Telomere
5%
Gene Locus
5%
Randomized Controlled Trial
5%
Body Mass
5%
Genetic Determinism
5%
Gene Expression Profiling
5%
Ventricular Tachycardia
5%
Hypovitaminosis D
5%
Nonsense Mutation
5%
Enterococcus
5%
